NCT03418038 2026-03-18Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic LeukemiaMayo ClinicPhase 2 Recruiting80 enrolled
NCT07097363 2026-01-15Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin LymphomaUniversity of WashingtonPhase 2 Recruiting18 enrolled